At the RNA level, we queried whether there was also a positive association between the expression of different stem cell markers (CD44, Nestin, SOX2 or LIF) and NOX4 expression in GBM patients from the REMBRANDT and the Granvendel databases. The gene discussed is NOX4; the disease is glioblastoma.